In vitro screening of phase I clinical compounds that disrupt the binding between PSD95 and nNOS

Choi, Seungbum; Kwon, Soonkyu; Han, Yujeong; Lee, Jiseon; Kim, Dong-Eog

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

In vitro screening of phase I clinical compounds that disrupt the binding between PSD95 and nNOSopen access

Authors: Choi, Seungbum; Kwon, Soonkyu; Han, Yujeong; Lee, Jiseon; Kim, Dong-Eog

Issue Date: Nov-2023

Publisher: KARGER

Keywords: Ischemic Stroke; PSD95; Drug Repurposing

Citation: Cerebrovascular Diseases, v.52, no.Suppl. 2, pp 29 - 29

Pages: 1

Indexed: SCIE
SCOPUS

Journal Title: Cerebrovascular Diseases

Volume: 52

Number: Suppl. 2

Start Page: 29

End Page: 29

URI: https://scholarworks.dongguk.edu/handle/sw.dongguk/19957

DOI: 10.1159/000534859

ISSN: 1015-9770
1421-9786

Files in This Item: There are no files associated with this item.

Appears in Collections: Graduate School > Department of Medicine > 1. Journal Articles

Show full item record

qrcode

Related Researcher

Researcher Kim, Dong Eog photo

Kim, Dong Eog: Graduate School (Department of Medicine)

Read more

Altmetrics

Total Views & Downloads

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Related Researcher

Altmetrics

Total Views & Downloads

BROWSE